Wei Ran
Sun Yat-sen University
7 Papers
7 Citations
Wei Ran is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 4, co-authored 4 publications.
Chat about Author
Papers
Accuracy of using computer-aided rapid prototyping templates for mandible reconstruction with an iliac crest graft.
TL;DR: The use of computer-aided rapid prototyping templates for virtual surgical planning appears to positively influence the accuracy of mandibular reconstruction.
PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c‐Myc‐mediated positive feedback loop
TL;DR: The role of pleckstrin‐2 (PLEK2) in regulating HNSCC tumorigenesis is explored to identify novel and promising therapeutic targets for H NSCC.
25
Superior biocompatibility and osteogenic efficacy of micro-arc oxidation-treated titanium implants in the canine mandible.
TL;DR: MAO treatment of titanium implantation outcomes and osteogenic efficacy of plasma micro-arc oxidation (MAO)-treated titanium implants in dogs promotes more rapid formation of new bone, and increases bone-implant shear strength compared to untreated titanium implants.
16
The Pseudomonas aeruginosa Mannose Sensitive Hamemagglutination Strain (PA-MSHA) Induces a Th1-Polarizing Phenotype by Promoting Human Dendritic Cells Maturation
TL;DR: It is demonstrated that PA-MSHA augmented monocytes derived-dendritic cells (Mo-DCs) expression of HLA-DR, co-stimulatory and adhesion molecules, and induced Th1-promoting interleukin-12 and tumor necrosis factor α secretion, in addition, PA- MSHA treated Mo- DCs displayed lesser endocytic capacity.
The immune checkpoint inhibitors treatment of head and neck squamous cell carcinoma: an expert consensus.
Lei Liu,Zhong-Zheng Xiang,Yi Liu,Wei Guo,Kai-Yan Yang,Jun Wang,Zhijun Sun,Guoxin Ren,Jianguo Zhang,Moyi Sun,Wei Ran,Guilin Huang,Zhangui Tang,Longjiang Li +13 more
TL;DR: In this article , the authors integrated the clinical experience of multi-disciplinary experts of head and neck cancers on the basis of current clinical hot issues and finally developed this consensus, to form a relatively unified understanding of immune checkpoint inhibitors treatment for head-and neck squamous cell carcinoma.
1